NVCR Q4 2019 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q4 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$99M+42.4% YoY

Gross Profit

$74M75.0% margin

Operating Income

$152,0000.2% margin

Net Income

$4M4.3% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$4M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$479M

Total Liabilities

$262M

Stockholders' Equity

$218M

Cash & Equivalents

$179M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$99M	$70M	+42.4%
Gross Profit	$74M	$47M	+59.6%
Operating Income	$152,000	-$9M	+101.8%
Net Income	$4M	-$16M	+127.3%

Geographic Segments

UNITED STATES

$66M187%

GERMANY

$22M64%

JAPAN

$6M16%

CHINA

$2M6%

EMEA

-$61M-173%